TPHA Test for Syphilis Diagnosis at Lahore PCR Lab

TPHA at Lahore PCR Lab

The Treponema Pallidum Hemagglutination Assay (TPHA) is a highly specific and sensitive serological blood test utilized to detect antibodies directed against Treponema pallidum, the spirochete bacterium responsible for syphilis. At Lahore PCR Lab, located in the heart of Lahore, Pakistan, this diagnostic investigation is performed using advanced immunodiagnostic systems to ensure maximum accuracy and clinical reliability. Syphilis is a sexually transmitted infection (STI) that progresses through distinct clinical stages—primary, secondary, latent, and tertiary. If left undiagnosed or untreated, it can lead to severe, irreversible systemic complications, including cardiovascular disease and neurosyphilis. The TPHA test serves as a cornerstone in the diagnostic algorithm of syphilis, primarily acting as a confirmatory test following a reactive non-treponemal screening test, such as the Venereal Disease Research Laboratory (VDRL) or Rapid Plasma Reagin (RPR) assay.

Unlike non-treponemal tests, which detect non-specific reaginic antibodies produced in response to cellular damage, the TPHA test specifically identifies treponemal antibodies (IgG and IgM) that target the structural antigens of the bacterium itself. The underlying technology of the TPHA test involves the hemagglutination process. In this assay, avian or mammalian red blood cells are sensitized with purified Treponema pallidum antigens. When these sensitized cells are mixed with a patient’s serum containing specific anti-treponemal antibodies, an antigen-antibody reaction occurs, causing the red blood cells to agglutinate and form a characteristic smooth mat at the bottom of the microtiter plate well. If no antibodies are present, the cells settle to form a compact button, indicating a negative result. This method provides high diagnostic value, particularly in the later stages of the disease, and is essential for preventing false-positive diagnoses that can occur with non-specific screening methods.

Clinical Procedure: What to Expect

Patient Preparation

• No Strict Fasting Required: Patients do not need to fast before undergoing a TPHA test. However, if the test is ordered alongside other investigations, such as a fasting blood sugar or lipid profile, fasting guidelines for those specific tests must be followed.
• Hydration: It is highly recommended to drink plenty of water before the blood draw, as proper hydration makes the veins more accessible and facilitates a smoother venipuncture process.
• Medication Disclosure: Inform the healthcare provider and the laboratory staff at Lahore PCR Lab about any ongoing medications, particularly antibiotics, immunosuppressants, or high-dose biotin supplements, as these can potentially interfere with laboratory assays.
• Avoid Alcohol and Strenuous Exercise: Refrain from consuming alcohol or engaging in intense physical exertion for at least 24 hours prior to the test to ensure optimal physiological baseline conditions.
• Identification and Documentation: Carry a valid government-issued identification card and the physician’s prescription, which may be required for registration and reporting purposes at Lahore PCR Lab.

During the Procedure

The TPHA test requires a standard venipuncture procedure to collect a blood sample. Upon arriving at Lahore PCR Lab, the patient is seated comfortably in a blood collection chair. A trained phlebotomist will verify the patient’s identity and explain the procedure. The phlebotomist will then inspect the patient’s arm, typically the antecubital fossa, to locate a suitable and accessible vein. Once a vein is selected, the area is thoroughly cleansed with an antiseptic solution, such as 70% isopropyl alcohol, and allowed to air dry to prevent contamination and minimize the risk of infection.

A sterile tourniquet is applied a few inches above the selected site to increase venous pressure and make the vein more prominent. The phlebotomist then inserts a sterile, single-use needle into the vein. Blood is drawn into a vacuum collection tube, typically a serum separator tube (SST) with a gold or red top. The tourniquet is released as soon as blood flow is established to prevent hemoconcentration. Once the required volume of blood is collected, the needle is gently withdrawn, and immediate pressure is applied to the puncture site with a sterile cotton ball or gauze pad to promote hemostasis. A small adhesive bandage is then applied over the site. The entire procedure is completed in less than five minutes, causing only minimal, temporary discomfort similar to a mild pinch. The collected sample is labeled immediately at the bedside with the patient’s unique identifiers to prevent any pre-analytical errors.

When is a TPHA Performed?

Confirmation of Reactive Syphilis Screening Tests

The primary clinical indication for performing a TPHA test at Lahore PCR Lab is to confirm a positive or reactive result obtained from non-treponemal screening tests, such as VDRL or RPR. Non-treponemal tests are highly sensitive and cost-effective for initial screening, but they are prone to biological false positives due to conditions like pregnancy, autoimmune diseases, viral infections, or chronic inflammation. Because the TPHA test detects antibodies specifically directed against Treponema pallidum antigens, it is highly specific. A positive TPHA result confirms the presence of true treponemal antibodies, allowing clinicians to confidently diagnose syphilis and initiate appropriate antibiotic therapy, thereby avoiding unnecessary treatment or psychological distress for the patient.

Evaluation of Patients with Symptoms of Syphilis

Physicians request a TPHA test when a patient presents with clinical signs and symptoms suggestive of syphilis. During the primary stage, this may include a painless ulcer known as a chancre at the site of inoculation (genitals, perineum, or mouth). In the secondary stage, symptoms may progress to a non-itchy maculopapular rash on the palms of the hands and soles of the feet, fever, swollen lymph nodes (lymphadenopathy), sore throat, patchy hair loss, and mucosal lesions. In late or tertiary syphilis, patients may present with neurological deficits, cardiovascular complications, or destructive granulomatous lesions called gummas. The TPHA test, in conjunction with clinical evaluation, helps confirm the diagnosis across these various stages.

Antenatal Screening and Prevention of Congenital Syphilis

Routine screening for syphilis is a standard component of prenatal care for all pregnant women. Untreated maternal syphilis can lead to devastating consequences, including miscarriage, stillbirth, premature birth, neonatal death, or severe congenital syphilis in the newborn, characterized by bone deformities, anemia, hepatosplenomegaly, and neurological impairment. If an initial screening test during pregnancy is reactive, a TPHA test is immediately performed at Lahore PCR Lab to confirm the diagnosis. Early detection and prompt treatment of infected pregnant women with penicillin can effectively prevent vertical transmission of the spirochete to the fetus, ensuring a healthy pregnancy outcome.

Screening of High-Risk Populations and Blood Donors

The TPHA test is widely used to screen individuals who are at a higher risk of contracting sexually transmitted infections, including those with multiple sexual partners, individuals diagnosed with other STIs (such as HIV, gonorrhea, or chlamydia), and men who have sex with men. Additionally, blood transfusion services utilize treponemal tests like TPHA to screen all donated blood units. This rigorous screening process is critical to preventing the transfusion-transmitted transmission of syphilis, safeguarding the blood supply, and protecting recipients from accidental infection.

Assessment of Late Latent or Tertiary Syphilis

In cases of latent syphilis, where the patient is completely asymptomatic but has a history of potential exposure, the TPHA test is invaluable. Non-treponemal tests (VDRL/RPR) can sometimes become non-reactive or show very low titers in late latent or tertiary syphilis due to a natural decline in reaginic antibodies over time. In contrast, treponemal antibodies detected by TPHA typically persist for life, even after successful treatment. Therefore, when a physician suspects late-stage syphilis, cardiovascular syphilis, or neurosyphilis based on clinical presentation or imaging, the TPHA test is performed to establish whether the patient has ever had a treponemal infection.

What Does a TPHA Detect?

The TPHA test at Lahore PCR Lab is designed to detect and evaluate several clinical parameters, antibody behaviors, and diagnostic indicators related to Treponema pallidum infection. Specifically, the test detects and helps differentiate the following:

• Treponema pallidum-Specific IgG Antibodies: The primary target of the TPHA assay, indicating a mature immunological response to the syphilis bacterium.
• Treponema pallidum-Specific IgM Antibodies: Present during the early phases of infection, helping to identify acute or recent exposure.
• Confirmatory Status: Validates reactive non-treponemal screening tests (VDRL/RPR) to rule out biological false positives.
• Serological Scarring: Detects persistent treponemal antibodies that remain in the blood for life following successful treatment.
• Active Secondary Syphilis: Demonstrates near 100% sensitivity during the secondary stage when antibody levels peak.
• Latent Syphilis Infection: Identifies asymptomatic individuals who carry the infection without presenting visible clinical symptoms.
• Tertiary Syphilis Exposure: Confirms historical exposure in patients presenting with late-stage cardiovascular or neurological symptoms.
• Congenital Syphilis Risk: Evaluates maternal antibody transfer to assess the risk of transmission to the fetus.
• Biological False Positives: Helps identify false-positive screening results caused by autoimmune conditions like Systemic Lupus Erythematosus (SLE).
• Spirochetal Cross-Reactivity: Detects antibodies that may cross-react with other non-venereal spirochetal infections such as Yaws or Pinta.
• Lyme Disease Cross-Reactivity: Identifies potential cross-reactivity with Borrelia burgdorferi, the causative agent of Lyme disease.
• Acute Viral Infection Interference: Rules out transient false-positive screenings caused by Epstein-Barr Virus (EBV) or Hepatitis.
• Leprosy and Tuberculosis Cross-Reactivity: Differentiates true syphilis from false-positive screens associated with chronic mycobacterial infections.
• True Negative Status: Confirms the absence of specific anti-treponemal antibodies in uninfected individuals.
• Early Primary Window Period: Identifies potential false negatives in very early primary syphilis before antibody titers reach detectable levels.
• Antibody Titers: Provides semi-quantitative analysis of antibody concentration through serial dilutions of the patient’s serum.
• Co-infection Markers: Serves as an indicator for broader sexual health screening, often prompting tests for HIV and Hepatitis B/C.
• Blood Donor Safety: Screens out contaminated blood units to ensure the safety of blood transfusions.
• Epidemiological Data: Contributes to public health tracking and surveillance of syphilis prevalence in the Lahore region.
• Post-Treatment Antibody Persistence: Demonstrates that the patient remains seropositive even after successful eradication of the spirochete.

Turnaround Time and Report Access at Lahore PCR Lab

At Lahore PCR Lab, we understand that timely and accurate diagnostic results are crucial for effective clinical decision-making and patient peace of mind. The TPHA test is processed in our state-of-the-art laboratory facility in Lahore using automated and semi-automated systems. The standard turnaround time for a TPHA test report is typically within 24 to 48 hours from the time of sample collection. Once the analysis is complete, the results undergo a rigorous multi-level quality control check and are validated by our consultant pathologists.

Patients can access their reports conveniently through multiple channels. Lahore PCR Lab provides an online portal on its official website, allowing patients to download their secure, password-protected PDF reports from the comfort of their homes. Additionally, an automated SMS notification is sent to the patient’s registered mobile number as soon as the report is ready, containing a direct link for quick access. Physical copies of the reports can also be collected from the laboratory’s main reception desk or designated collection centers across Lahore.

TPHA Findings Overview

Parameter Evaluated	Normal Findings	Possible Abnormal Findings
TPHA Qualitative Screen	Non-Reactive (No agglutination)	Reactive (Agglutination observed)
TPHA Quantitative Titer	Titer < 1:80 (Negative)	Titer ≥ 1:80 (Positive, indicating antibody presence)
Primary Syphilis Status	Non-Reactive (in very early stages)	Reactive (as specific antibodies begin to develop)
Secondary Syphilis Status	Non-Reactive (extremely rare)	Strongly Reactive (highest antibody titers observed)
Latent Syphilis Status	Non-Reactive	Reactive (antibodies persist despite lack of symptoms)
Post-Treatment Status	Non-Reactive (rarely, if treated very early)	Persistently Reactive (known as a serological scar)
Biological False Positive	Non-Reactive	Weakly Reactive (due to cross-reacting non-syphilitic antibodies)
Congenital Syphilis Evaluation	Non-Reactive (in healthy neonates)	Reactive (requires correlation with maternal titers and IgM testing)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Lahore PCR Lab for TPHA?

• Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified pathologists, microbiologists, and technologists dedicated to diagnostic excellence.
• Patient-Focused Care: We prioritize patient comfort, confidentiality, and clear communication throughout the testing process.
• Quality Diagnostic Services: Lahore PCR Lab adheres to strict internal and external quality control protocols to ensure maximum accuracy.
• Professional Reporting: Reports are detailed, structured, and easy for both patients and referring physicians to interpret.
• Modern Diagnostic Approach: We utilize advanced immunodiagnostic equipment and methodology for precise antibody detection.
• Comfortable Environment: Our collection centers in Lahore are designed to provide a clean, hygienic, and stress-free experience.
• Convenient Location: Easily accessible facilities across Lahore make it simple for patients to undergo testing.
• Commitment to Accurate Diagnosis: We are dedicated to providing reliable results that clinicians can trust for patient management.